Clairity to Present AI Research in Breast Cancer Risk Prediction at RSNA 2025

tim.hodson

Tue, 10/07/2025 – 12:51

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific presentations featuring its FDA-authorized image-only AI model at the Radiological Society of North America (RSNA) 2025 Annual Meeting, Nov. 30 to Dec. 4 in Chicago. The studies highlight Clairity’s approach to estimating 5-year breast cancer risk from a single screening mammogram and demonstrate the model’s clinical accuracy, calibration, a…

Read the full article on itnonline.com